Author:
Alessandrino Francesco,Sahu Sonia,Nishino Mizuki,Adeni Anika E.,Tirumani Sree Harsha,Shinagare Atul B.,Awad Mark M.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference39 articles.
1. Opdivo. Full prescribing information. U. S. Food and Drug Administration/Center for Drug Evaluation and Research.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125554s055lbl.pdf
. Published December 2014. Updated December 2017. Accessed September 21, 2018.
2. D'Angelo SP, Mahoney MR, Van Tine BA, et al (2018) Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. Lancet Oncol 19(3):416-426.
3. Fife BT, Pauken KE, Eagar TN, et al (2009) Interactions between programmed death-1 and programmed death ligand-1 promote tolerance by blocking the T cell receptor-induced stop signal. Nat immunol 10(11):1185-1192.
4. Dong H, Strome SE, Salomao DR, et al (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8(8):793-800.
5. Francisco LM, Salinas VH, Brown KE, et al (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206(13):3015-3029.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献